Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
Murray, Heather M
Blauw, Gerard J
Buckley, Brendan M
de Craen, Anton J M
Lowe, Gordon D
Jukema, J Wouter
Macfarlane, Peter W
Murphy, Michael B
Stott, David J
Westendorp, Rudi G J
Packard, Chris J
AffiliationDivision of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, Scotland, UK. firstname.lastname@example.org
Aged, 80 and over
MetadataShow full item record
CitationAre markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? 2009, 6 (6):e1000099 PLoS Med.
AbstractCirculating inflammatory markers may more strongly relate to risk of fatal versus nonfatal cardiovascular disease (CVD) events, but robust prospective evidence is lacking. We tested whether interleukin (IL)-6, C-reactive protein (CRP), and fibrinogen more strongly associate with fatal compared to nonfatal myocardial infarction (MI) and stroke.
In the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER), baseline inflammatory markers in up to 5,680 men and women aged 70-82 y were related to risk for endpoints; nonfatal CVD (i.e., nonfatal MI and nonfatal stroke [n = 672]), fatal CVD (n = 190), death from other CV causes (n = 38), and non-CVD mortality (n = 300), over 3.2-y follow-up. Elevations in baseline IL-6 levels were significantly (p = 0.0009; competing risks model analysis) more strongly associated with fatal CVD (hazard ratio [HR] for 1 log unit increase in IL-6 1.75, 95% confidence interval [CI] 1.44-2.12) than with risk of nonfatal CVD (1.17, 95% CI 1.04-1.31), in analyses adjusted for treatment allocation. The findings were consistent in a fully adjusted model. These broad trends were similar for CRP and, to a lesser extent, for fibrinogen. The results were also similar in placebo and statin recipients (i.e., no interaction). The C-statistic for fatal CVD using traditional risk factors was significantly (+0.017; p<0.0001) improved by inclusion of IL-6 but not so for nonfatal CVD events (p = 0.20).
In PROSPER, inflammatory markers, in particular IL-6 and CRP, are more strongly associated with risk of fatal vascular events than nonfatal vascular events. These novel observations may have important implications for better understanding aetiology of CVD mortality, and have potential clinical relevance.
- C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
- Authors: Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Shepherd J, PROSPER Study Group.
- Issue date: 2007 Feb 27
- Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study.
- Authors: Zakai NA, Katz R, Jenny NS, Psaty BM, Reiner AP, Schwartz SM, Cushman M
- Issue date: 2007 Jun
- Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults.
- Authors: Jenny NS, Arnold AM, Kuller LH, Sharrett AR, Fried LP, Psaty BM, Tracy RP
- Issue date: 2006 Jan
- Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
- Authors: Corrado E, Rizzo M, Muratori I, Coppola G, Novo S
- Issue date: 2008 Mar-Apr
- Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.
- Authors: Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C
- Issue date: 2011 Jan